North East and North Cumbria
ICS Formulary
8 Malignant disease and immunosuppression
08-01 Drugs for cytotoxic-induced side-effects
Calcium Folinate
Formulary
Approved for methotrexate-induced mucositis and myelosuppression. The following formulations are approved:
15mg tablets.
3mg, 15mg, 30mg, and 300mg injections
A calcium folinate 1mg per ml mouthwash can be prepared if needed.
unlicensed
Dexrazoxane
Savene
®
Formulary
For use in line with NECN extravasation.
Mesna
Formulary
Approved formulations include 1gram in 10ml injection and 400mg tablets.
Glucarpidase
Formulary
Approved for the urgent treatment of methotrexate-induced renal
dysfunction.
NHS England: Glucarpidase for the urgent treatment of methotrexateinduced renal dysfunction
Links
Cancer Drug Fund List
NHS England: Glucarpidase for the urgent treatment of methotrexateinduced renal dysfunction
NICE TA408: Pegaspargase for treating acute lymphoblastic leukaemia
Northern Cancer Alliance
Northern England Clinical Networks Palliative and End of Life Care Guidelines
Key
Full Site